Table 5. Fifty-nine unique criteria identified collectively by six focus groups for prioritizing zoonotic diseases in Canada (Part 2).
| Criteria | Theme | Human, animal, pathogen or disease | Public Groups | Professional Groups | Mean Score∧ | Frequency# | |||||
| 1 | 2 | 3 | AH+ | HH+ | A/H+ | ||||||
| 25 | Mode of transmission | Disease epidemiology | Pathogen/disease | 1‡ | 1 | 1 | 1 | 1 | 1 | 7.2 | 6 |
| 26 | Pathogenicity and virulence of the pathogen | Disease epidemiology | Pathogen/disease | 1 | 2 | 6.7 | 2 | ||||
| 27 | Range of pathogens | Disease epidemiology | Pathogen/disease | 1 | 6.8 | 1 | |||||
| 28 | Disease trend | Disease epidemiology | Pathogen/disease | 1 | 1 | 1 | 1 | 6.2 | 4 | ||
| 29 | Ability of the pathogen to mutate and adapt to change | Disease epidemiology | Pathogen/disease | 1 | 1 | 2 | 3 | 5.8 | 4 | ||
| 30 | Endemicity of the disease due to climate | Disease epidemiology | Pathogen/disease | 1 | 1 | 4.1 | 2 | ||||
| 31 | Seasonality of the disease | Disease epidemiology | Pathogen/disease | 1 | 1 | 1 | 3.5 | 3 | |||
| 32 | Treatment and prevention in humans | Control measures | Human | 2 | 4 | 2 | 2 | 2 | 1 | 7.2 | 6 |
| 33 | Potential to eradicate the disease in humans | Control measures | Human | 1 | 1 | 1 | 6.5 | 3 | |||
| 34 | Visual cues to avoid the disease in humans | Control measures | Human | 1 | 1 | 1 | 6.0 | 3 | |||
| 35 | Surveillance in humans | Control measures | Human | 1 | 5.9 | 1 | |||||
| 36 | Human cause versus a natural cause | Control measures | Human | 1 | 5.9 | 1 | |||||
| 37 | Disease in human beyond control measures | Control measures | Human | 1 | 1 | 5.8 | 2 | ||||
| 38 | Vaccine/antiviral manufacturing time | Control measures | Human | 1 | 5.8 | 1 | |||||
| 39 | Potential to eradicate the disease in animals | Control measures | Animal | 1 | 6.5 | 1 | |||||
| 40 | Treatment and prevention in animals | Control measures | Animal | 1 | 2 | 1 | 6.2 | 3 | |||
| 41 | Surveillance in animals | Control measures | Animal | 1 | 5.6 | 1 | |||||
| 42 | Risk of bioterrorism | Socioeconomic impact | Human | 1 | 1 | 6.7 | 2 | ||||
| 43 | Political impact of the disease in humans | Socioeconomic impact | Human | 1 | 6.4 | 1 | |||||
| 44 | Risk to the food and water supply | Socioeconomic impact | Human | 1 | 2 | 6.4 | 2 | ||||
| 45 | Socioeconomic burden of the disease in humans | Socioeconomic impact | Human | 1 | 2 | 2 | 2 | 1 | 1 | 5.6 | 6 |
| 46 | Psychological impact in humans | Socioeconomic impact | Human | 1 | 5.4 | 1 | |||||
| 47 | Socioeconomic burden of the disease at the individual/farm level | Socioeconomic impact | Animal | 1 | 1 | 5.8 | 2 | ||||
| 48 | Socioeconomic burden of the disease on the industry | Socioeconomic impact | Animal | 1 | 1 | 1 | 2 | 6.3 | 4 | ||
+
AH = animal health professional group, HH = human health professional group and A/H = mixed animal and human health professional group.
∧
Mean score on a scale of 1 being the least important to 9 being the most important.
#
The number of focus groups that identified the unique criterion; 1 indicates only one focus group listed the criterion while 6 indicates all focus groups listed the criterion.
‡
The number of times the unique criterion was identified by each focus group; 2 or more indicates the criterion was listed more than once but expressed in different terms by the focus group.